MP:0000150 | abnormal rib morphology | "malformed bones forming the bony wall of the chest" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:50311] |
Show
Allelic Composition: Mecomtm1Miku/Mecomtm1Miku,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco,Rfngtm1Tfv/Rfngtm1Tfv Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
|
MP:0000222 | decreased neutrophil count | "fewer than normal neutrophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0001539 | decreased number of caudal vertebrae | "reduced number of the bony segments of the tail" [Stedman s Medical Dictionary, 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mecomtm1Miku/Mecomtm1Miku,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco,Rfngtm1Tfv/Rfngtm1Tfv Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
|
MP:0001570 | abnormal circulating enzyme level | "aberrent concentration in the blood of any of the proteins that act as catalysts for biological reactions" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Mecomtm1Miku/Mecomtm1Miku,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0003396 | abnormal embryonic hematopoiesis | "anomaly in the development of primarily large, nucleated erythroblasts as well as some megakaryocytes and primitive macrophages occuring in blood islands in the yolk sac, generally occurs from E7-E11 in the mouse and through 10 weeks in humans
" [J:94136, smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Cjg/Mfngtm1Cjg Genetic Background: B6.Cg-Lfngtm1Rjo Mfngtm1Cjg
|
MP:0003884 | decreased macrophage count | "fewer than the normal numbers of macrophages" [acv:Alicia Valenzuela, Genetic Resources Curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0005013 | increased lymphocyte number | "greater than normal white blood cell numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0005014 | increased B cell number | "greater than normal B cell numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0005154 | increased B cell proliferation | "greater than the normal response by B cells to grow and divide in response to stimuli " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0005508 | abnormal skeleton morphology | "malformation of the bony framework of the body in vertebrates" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mecomtm1Miku/Mecomtm1Miku,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco,Rfngtm1Tfv/Rfngtm1Tfv Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
|
MP:0008180 | abnormal marginal zone B cell morphology | "any structural anomaly of a CD23-negative, CD21-positive B cell of the marginal zone of the spleen expressing a B cell receptor usually reactive to bacterial cell wall components or senescent self components such as oxidized-LDL" [CL:0000845, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Dact1tm1.1Bnrc/Dact1+,Vangl2Lp-m1Jus/Vangl2+ Genetic Background: involves: 101/Rl * 129 * C3H/Rl * C57BL/6
|
MP:0008211 | decreased mature B cell number | "reduced number of the mature form of B cells, a type of lymphocyte whose defining characteristic is the expression of an immunoglobulin complex" [CL:0000785, ISBN:0781735149] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0008770 | decreased survivor rate | "a smaller percentage of organisms than expected survive to adulthood and have a lifespan similar to controls" [MGI:llw2 "Linda Washburn, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mecomtm1Miku/Mecomtm1Miku,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco,Rfngtm1Tfv/Rfngtm1Tfv Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
|
MP:0011086 | partial postnatal lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms anytime between the neonatal period and weaning age (Mus: P1 to approximately 3 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
Allelic Composition: Lfngtm1Rjo/Lfngtm1Rjo,Mfngtm1Seco/Mfngtm1Seco,Rfngtm1Tfv/Rfngtm1Tfv Genetic Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/NJ
|
MP:0012355 | decreased prothrombin time | "decreased amount of time it takes plasma to clot after the addition of tissue factor e.g., platelet tissue factor, factor III, thromboplastin, CD142; measure of the quality of the extrinsic pathway of coagulation" [MPD:Molly] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0012358 | decreased partial thromboplastin time | "decreased amount of time it takes blood to clot after the addition of phospholipid, calcium, and an activator, e.g., silica, kaolin; measure of the quality of the intrinsic and common coagulation pathways" [MPD:Molly] |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|
MP:0012616 | increased circulating factor IX level | |
Show
Allelic Composition: Smad4tm2.1Cxd/Smad4tm2.1Cxd,Tg(Pou5f1-cre/ERT2)#Ysa/0 Genetic Background: involves: 129S6/SvEvTac
|